Alzheimer’s disease is one of the most common and devastating brain disorders in the world. It slowly destroys memory, thinking ability, and even basic functions like speaking and recognizing loved ones.
For many years, scientists believed that most of the damage in Alzheimer’s came from harmful protein clumps and constant inflammation in the brain. However, new research is now revealing that some of the brain’s own immune cells may actually have the power to protect the brain if they are guided in the right way.
In this new study, researchers worked with Alzheimer’s mouse models, human brain cells grown in the lab, and donated brain tissue from people. They focused on a special type of brain immune cell called microglia.
Microglia live in the brain and act like cleaners and guards. They remove waste, fight infections, and help keep brain cells healthy. For a long time, microglia were believed to mostly contribute to damage in Alzheimer’s because they can trigger inflammation. But this study shows that microglia can also play a protective role.
The scientists discovered that when the levels of a molecule called PU.1 are lowered, microglia change their behavior. Instead of promoting inflammation, they shift into a protective mode.
In this state, the microglia begin to produce more of certain helpful immune-related proteins, including a key one called CD28. These proteins usually help control immune responses in the rest of the body, but in this case, they appear to help the brain calm down harmful inflammation.
Even though only a small number of microglia took on this protective role, their impact was powerful.
The presence of these special microglia helped reduce overall brain inflammation, supported thinking and memory abilities, and even improved survival in mice that were affected by Alzheimer’s-like disease. In other words, a tiny group of cells had a big influence across the entire brain.
To test how important this change really was, the research team removed the CD28 protein from these special microglia.
When they did that, the results were dramatic. Inflammation in the brain increased quickly, and the sticky plaques commonly linked to Alzheimer’s disease built up much faster. This showed that CD28 is essential for these microglia to carry out their helpful, protective functions.
Anne Schaefer, the lead researcher of the study, explained that microglia are far more flexible than once believed. She said that they are not only destructive cells that worsen disease.
Instead, they can become defenders of the brain when guided in the right direction. She also emphasized that this discovery was made possible through international teamwork and collaboration, which is especially important in complex diseases like Alzheimer’s.
Another researcher, Alexander Tarakhovsky, pointed out that the immune-related molecules found in this study are usually seen in other immune cells, such as B cells and T cells.
Seeing these same molecules working inside microglia was surprising and exciting. It suggests that the immune system follows similar rules in different parts of the body, including the brain. This shared system could one day lead to new types of immune-based treatments for Alzheimer’s disease.
The research also connects to earlier genetic studies. Scientist Alison Goate had previously found that people with a certain variation in the SPI1 gene, which controls PU.1 levels, have a lower risk of developing Alzheimer’s.
This new study helps explain why. Lower PU.1 leads to more protective microglia, which may slow down or reduce the damage seen in Alzheimer’s disease. This gives scientists a clearer picture of how genetics can affect a person’s risk of getting the disease.
After reviewing the findings, this study appears to be a significant breakthrough. It shows that Alzheimer’s is not only driven by damage, but also by a battle within the brain between harmful and helpful immune responses. By reducing PU.1 and supporting the CD28 pathway, scientists may be able to encourage the brain to protect itself.
This opens the door to new treatment strategies that focus on guiding microglia toward a protective role instead of trying to eliminate them. Although more research is still needed, this discovery provides real hope that future therapies could slow or even prevent the progression of Alzheimer’s disease.
If you care about Alzheimer’s disease, please read studies about the protective power of dietary antioxidants against Alzheimer’s, and eating habits linked to higher Alzheimer’s risk.
For more health information, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.
The study is published in Nature.
Copyright © 2025 Knowridge Science Report. All rights reserved.
